TY - JOUR T1 - RGC-TBRS Personal Air Pollutant Exposure versus Health Condition and Perception Pilot Study for Young Asthmatics in Hong Kong (2019/2020) JF - medRxiv DO - 10.1101/2021.06.22.21259358 SP - 2021.06.22.21259358 AU - Kenyon Chow AU - Yang Han AU - Victor OK Li AU - Jacqueline CK Lam AU - So-lun Lee AU - Wilfred Wong AU - Yu-lung Lau Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/25/2021.06.22.21259358.abstract N2 - This is a report of the RGC-TBRS funded observational pilot study which examines the effects of personal exposures to three types of air pollutants, namely, PM1.0, PM2.5, and PM10, on personal health condition and perception of young asthmatics (aged 12 – 15) in Hong Kong. This is the first study to investigate the relationship between PM1.0 and FEV1 and FVC of young asthmatics in Hong Kong, based on personal exposures obtained from portable sensors. Our preliminary results show that a higher level of PM1.0, PM2.5 and PM10 would deteriorate the health conditions of young asthmatics in HK. All correlations between particulates and lung functions are significant and negative, including PM1.0 exposure vs. FEV1 (R2=12%; p=0.023), PM1.0 exposure vs. FVC (R2=15%; p=0.010), PM2.5 exposure vs. FEV1 (R2=13%; p=0.019), PM2.5 exposure vs. FVC (R2=16%; p=0.008), PM10 exposure vs. FEV1 (R2=14%; p=0.012), and PM10 exposure vs. FVC (R2=18%; p=0.005). Moreover, after accounting for covariates, including age, gender, body mass index (BMI), temperature, and relative humidity, we found a significant relationship between PM1.0 exposure vs. FVC (Coefficient=-0.1224; p=0.032), PM2.5 exposure vs. FVC (Coefficient=-0.1177; p=0.021), PM10 exposure vs. FEV1 (Coefficient=-0.0703; p=0.019), and PM10 exposure vs. FVC (Coefficient=-0.1204; p=0.006). Further, using the pilot study data, we have performed a power analysis to estimate the sample size for our follow-up main study. Based on the primary null hypothesis that personal PM exposure would not change the FEV1 and FVC of young asthmatics in HK, the lowest sample size that gives 80% power at a 5% significance level is 107. Hence, the sample size (or the total number of participated asthma subjects) expected for the follow-up longitudinal clinical study should be 125 (after adjusting for the non-compliance and withdrawal of subjects). Our pilot study has demonstrated the feasibility of research into the effects of personal air pollutant exposure on health condition and health perception. Our follow-up study will address the challenges identified in the pilot study, based on the proposed follow-up actions for subject engagement, data collection, and data analysis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is supported by the Theme-based Research Scheme of the Research Grants Council of the Hong Kong SAR Government, under Grant No. T41-709/17-N.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of The University of Hong Kong/ Hospital Authority Hong Kong West Cluster.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFigure 1 and Table 1-4 have all associated raw data available on the group's Microsoft Azure server that will be released on a later date. ER -